{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:10:15Z","timestamp":1780434615745,"version":"3.54.1"},"reference-count":330,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.dld.2021.03.035","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T11:48:05Z","timestamp":1622288885000},"page":"S49-S86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"S2","title":["Position paper on liver and kidney diseases from the Italian Association for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN)"],"prefix":"10.1016","volume":"53","author":[{"given":"Maria Cristina","family":"Morelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rendina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"La Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Alessandria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Pasulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Lenci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherrie","family":"Bhoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiorgio","family":"Messa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Biancone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Petta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Burra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2021.03.035_bib0001","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.dld.2021.03.035_bib0002","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/liv.13498","article-title":"Spectrum of hepatitis B and renal involvement","volume":"38","author":"Shah","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0003","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.dld.2018.08.022","volume":"50","author":"Minutolo","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2021.03.035_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3851\/IMP3246","article-title":"Expert opinion on managing chronic HCV in patients with mixed cryoglobulinaemia vasculitis","volume":"23","author":"Zignego","year":"2018","journal-title":"Antivir Ther"},{"key":"10.1016\/j.dld.2021.03.035_bib0005","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/s10620-016-4199-x","article-title":"Prevalence of Renal Impairment and Associated Conditions Among HCV-Infected Persons in the Chronic Hepatitis Cohort Study (CHeCS)","volume":"61","author":"Moorman","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2021.03.035_bib0006","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0272-6386(03)00024-6","article-title":"Hepatitis C virus-associated tubulointerstitial injury","volume":"41","author":"Kasuno","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.dld.2021.03.035_bib0007","series-title":"Liv er disease and the kidney","author":"Gin\u00e8s P","year":"2007"},{"key":"10.1016\/j.dld.2021.03.035_bib0008","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cgh.2014.07.011","article-title":"Risk factors and outcomes of acute kidney injury in patients with acute liver failure","volume":"13","author":"Tujios","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0009","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.03.035_bib0010","first-page":"1","article-title":"Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int Supp"},{"key":"10.1016\/j.dld.2021.03.035_bib0011","first-page":"164","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0012","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/lt.24210","article-title":"Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes","volume":"21","author":"Rodriguez","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2021.03.035_bib0013","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2013.03.039","article-title":"Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites","volume":"59","author":"Piano","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0014","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/lt.22128","article-title":"Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score","volume":"16","author":"Francoz","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2021.03.035_bib0015","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/hep.26886","article-title":"Creatinine- versus cystatine C-based equations in assessing the renal function of candidates for liver transplantation with cirrhosis","volume":"59","author":"De Souza","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0016","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jhep.2014.02.023","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections","volume":"61","author":"Barreto","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0017","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.30592","article-title":"Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study","volume":"70","author":"Huelin","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0018","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jhep.2016.03.002","article-title":"Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis","volume":"65","author":"Ariza","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0019","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cgh.2016.11.035","article-title":"Urine Interleukin 18 and Lipocalin 2 Are Biomarkers of Acute Tubular Necrosis in Patients With Cirrhosis: A Systematic Review and Meta-analysis","volume":"15","author":"Puthumana","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0020","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1172\/JCI75417","article-title":"KIM-1-mediated phagocytosis reduces acute injury to the kidney","volume":"125","author":"Yang","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.dld.2021.03.035_bib0021","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2215\/CJN.09430913","article-title":"Urinary biomarkers and progression of AKI in patients with cirrhosis","volume":"9","author":"Belcher","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0022","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.crad.2014.06.011","article-title":"Assessment of renal fibrosis in chronic kidney disease using diffusion-weighted MRI","volume":"69","author":"Zhao","year":"2014","journal-title":"Clin Radiol"},{"key":"10.1016\/j.dld.2021.03.035_bib0023","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.1007\/s00330-019-06331-4","article-title":"Prospective comparison of transient, point shear wave, and magnetic resonance elastography for staging liver fibrosis","volume":"29","author":"Lefebvre","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.dld.2021.03.035_bib0024","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/jmri.24826","article-title":"Reliability of magnetic resonance elastography using multislice two-dimensional spin-echo echo-planar imaging (SE-EPI) and three-dimensional inversion reconstruction for assessing renal stiffness","volume":"42","author":"Low","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.dld.2021.03.035_bib0025","first-page":"414","article-title":"Glomerulopathy with liver disease: patterns and management","volume":"11","author":"Dash","year":"2000","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.dld.2021.03.035_bib0026","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1478-3231.2009.02182.x","article-title":"The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study","volume":"30","author":"Trawale","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0027","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jhep.2012.04.028","article-title":"Prospective assessment of renal histopathological lesions in patients with end-stage liver disease: effects on long-term renal function after liver transplantation","volume":"57","author":"Calmus","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0028","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0046-8177(86)80419-1","article-title":"Glomerular lesions associated with liver cirrhosis: an immunohistochemical and clinicopathologic analysis","volume":"17","author":"Kawaguchi","year":"1986","journal-title":"Hum Pathol"},{"key":"10.1016\/j.dld.2021.03.035_bib0029","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/hep.510240527","article-title":"Transjugular renal biopsy in the treatment of patients with cirrhosis and renal abnormalities","volume":"24","author":"Jou\u00ebt","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193274","article-title":"Acute glomerulonephritis with large confluent IgA-dominant deposits associated with liver cirrhosis","volume":"13","author":"Hemminger","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2021.03.035_bib0031","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/hep.30859","article-title":"Incidence, risk factors, and outcomes of transition of acute kidney injury to chronic kidney disease in cirrhosis: a prospective cohort study","volume":"71","author":"Maiwall","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0032","doi-asserted-by":"crossref","first-page":"27k","DOI":"10.1016\/j.amjcard.2006.01.022","article-title":"Risk prediction of contrast-induced nephropathy","volume":"98","author":"McCullough","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.dld.2021.03.035_bib0033","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJM198901193200303","article-title":"Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. a prospective controlled study","volume":"320","author":"Parfrey","year":"1989","journal-title":"N Engl J Med"},{"issue":"Suppl 5","key":"10.1016\/j.dld.2021.03.035_bib0034","first-page":"S28","article-title":"Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality","volume":"4","author":"Rudnick","year":"2003","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.dld.2021.03.035_bib0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1148\/radiol.13130775","article-title":"Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate","volume":"271","author":"McDonald","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.dld.2021.03.035_bib0036","doi-asserted-by":"crossref","first-page":"W188","DOI":"10.2214\/AJR.19.21424","article-title":"Influence of Clinical Factors on Risk of Contrast-Induced Nephrotoxicity From IV Iodinated Low-Osmolality Contrast Material in Patients With a Low Estimated Glomerular Filtration Rate","volume":"213","author":"Ellis","year":"2019","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.dld.2021.03.035_bib0037","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1148\/radiol.13122276","article-title":"Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate","volume":"268","author":"Davenport","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.dld.2021.03.035_bib0038","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3748\/wjg.15.1459","article-title":"Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis","volume":"15","author":"Lodhia","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2021.03.035_bib0039","doi-asserted-by":"crossref","first-page":"e4836","DOI":"10.1097\/MD.0000000000004836","article-title":"Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography","volume":"95","author":"Filomia","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.dld.2021.03.035_bib0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.krcp.2012.04.317","article-title":"Intravenous albumin for the prevention of contrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease undergoing contrast-enhanced CT","volume":"31","author":"Choi","year":"2012","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.dld.2021.03.035_bib0041","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.ajkd.2019.05.022","article-title":"The Controversy of Contrast-Induced Nephropathy With Intravenous Contrast: What Is the Risk?","volume":"75","author":"Rudnick","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.dld.2021.03.035_bib0042","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2011.10.016","article-title":"Renal failure and cirrhosis: a systematic review of mortality and prognosis","volume":"56","author":"Fede","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0043","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/ndt\/gfh839","article-title":"Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis","volume":"20","author":"Proulx","year":"2005","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.dld.2021.03.035_bib0044","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/hep.26704","article-title":"Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations","volume":"59","author":"Francoz","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0045","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jhep.2018.12.030","article-title":"Estimation of renal function in patients with liver cirrhosis: Impact of muscle mass and sex","volume":"70","author":"Yoo","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0046","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/hep.30321","article-title":"A Model for Glomerular Filtration Rate Assessment in Liver Disease (GRAIL) in the Presence of Renal Dysfunction","volume":"69","author":"Asrani","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0047","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/hep.28891","article-title":"Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: The royal free hospital cirrhosis glomerular filtration rate","volume":"65","author":"Kalafateli","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0048","first-page":"1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group KDIGO Clinical Practice Guideline for Acute Kidney Injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.dld.2021.03.035_bib0049","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0050","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0051","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/hep.29303","article-title":"Significance of Oliguria in Critically Ill Patients With Chronic Liver Disease","volume":"66","author":"Amathieu","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0052","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/jhep.2003.50084","article-title":"Acute renal failure in patients with cirrhosis: perspectives in the age of MELD","volume":"37","author":"Moreau","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0053","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2013.04.036","article-title":"A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis","volume":"59","author":"Fagundes","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0054","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cgh.2016.09.156","article-title":"Validation of a staging system for acute kidney injury in patients with cirrhosis and association with acute-on-chronic liver failure","volume":"15","author":"Huelin","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2007.10.055","article-title":"Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis","volume":"134","author":"Stadlbauer","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.03.035_bib0056","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gin\u00e8s","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2021.03.035_bib0057","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","article-title":"Mechanisms of disease - Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis","volume":"339","author":"Martin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2021.03.035_bib0058","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/0140-6736(91)91384-7","article-title":"Hyperdynamic circulation in cirrhosis - a role for nitric-oxide","volume":"337","author":"Vallance","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2021.03.035_bib0059","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0168-8278(03)00007-2","article-title":"Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management","volume":"38","author":"Arroyo","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0060","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis","volume":"63","author":"Bernardi","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0061","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0062","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1681\/ASN.2017020146","article-title":"Preventing the progression of AKI to CKD: the role of mitochondria","volume":"28","author":"de Seigneux","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0063","article-title":"Hepatorenal syndrome","volume":"4","author":"Gines","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.dld.2021.03.035_bib0064","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhep.2016.05.025","article-title":"Kidney biomarkers in cirrhosis","volume":"65","author":"Francoz","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0065","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in Cirrhosis","volume":"48","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0066","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","article-title":"Prognostic importance of the cause of renal failure in patients with Cirrhosis","volume":"140","author":"Martin-Llahi","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.03.035_bib0067","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cgh.2012.11.007","article-title":"Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials","volume":"11","author":"Salerno","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0068","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"Clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0069","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2021.03.035_bib0070","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0071","first-page":"457","article-title":"Renal dysfunction and cirrhosis","volume":"23","author":"Durand","year":"2017","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.dld.2021.03.035_bib0072","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/ajg.2009.3","article-title":"Oral antibiotic prophylaxis reduces spontaneous bacterial peritonitis occurrence and improves short-term survival in Cirrhosis: a meta-analysis","volume":"104","author":"Saab","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2021.03.035_bib0073","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2214\/AJR.13.11369","article-title":"The challenges in assessing contrast-induced nephropathy: where are we now?","volume":"202","author":"Davenport","year":"2014","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.dld.2021.03.035_bib0074","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2015.10.019","article-title":"Management of the critically ill patient with cirrhosis: a multidisciplinary perspective","volume":"64","author":"Nadim","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0075","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.dld.2021.03.035_bib0076","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2019.03.021","article-title":"Effects of Albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis","volume":"157","author":"Fernandez","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.03.035_bib0077","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0078","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome Type 1","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.03.035_bib0079","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005162.pub4","article-title":"Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome","author":"Allegretti","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2021.03.035_bib0080","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S2468-1253(16)30157-1","article-title":"Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis","volume":"2","author":"Facciorusso","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0081","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: A prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0082","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jhep.2012.06.024","article-title":"Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice","volume":"57","author":"Angeli","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0083","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis European Association for the Study of the Liver","volume":"53","author":"Gines","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0084","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0085","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.cgh.2018.01.035","article-title":"Association between grade of acute on chronic liver failure and response to terlipressin and albumin in patients with hepatorenal syndrome","volume":"16","author":"Piano","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0086","article-title":"Terlipressin versus Norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis","volume":"9","author":"Nassar","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2021.03.035_bib0087","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/hep.30282","article-title":"Reply","volume":"68","author":"Arora","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0088","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0089","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2007.06.020","article-title":"Transjugular intrahepatic portosystemic shunt for refractory ascites: A meta-analysis of individual patient data","volume":"133","author":"Salerno","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.03.035_bib0090","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jcrc.2015.03.025","article-title":"Associations of fluid overload with mortality and kidney recovery in patients with acute kidney injury: a systematic review and meta-analysis","volume":"30","author":"Zhang","year":"2015","journal-title":"J Crit Care"},{"key":"10.1016\/j.dld.2021.03.035_bib0091","doi-asserted-by":"crossref","first-page":"S459","DOI":"10.1016\/S0168-8278(10)61185-3","article-title":"Extracorporeal liver support with the molecular adsorbent recirculating system (MARS) in patients with acute-on-chronic liver failure (AoCLF)","volume":"52","author":"Banares","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0092","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000086552","article-title":"The Prometheus device for extracorporeal support of combined liver and renal failure","volume":"23","author":"Rifai","year":"2005","journal-title":"Blood Purif"},{"key":"10.1016\/j.dld.2021.03.035_bib0093","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ki.2012.208","article-title":"Acute kidney injury and chronic kidney disease: an integrated clinical syndrome","volume":"82","author":"Chawla","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0094","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ki.2011.42","article-title":"The severity of acute kidney injury predicts progression to chronic kidney disease","volume":"79","author":"Chawla","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0095","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0096","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","article-title":"Acute kidney injury","volume":"380","author":"Bellomo","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2021.03.035_bib0097","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrneph.2015.3","article-title":"Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD","volume":"11","author":"Ferenbach","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0098","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinbiochem.2018.07.003","article-title":"The multiple functions and mechanisms of osteopontin","volume":"59","author":"Icer","year":"2018","journal-title":"Clin Biochem"},{"key":"10.1016\/j.dld.2021.03.035_bib0099","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1620\/tjem.237.103","article-title":"Diagnostic Value of Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis-Associated Acute Kidney Injury","volume":"237","author":"Bojic","year":"2015","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.dld.2021.03.035_bib0100","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/hep.30667","article-title":"External validation of a pretransplant biomarker model (reverse) predictive of renal recovery after liver transplantation","volume":"70","author":"Levitsky","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0101","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1136\/gutjnl-2014-307526","article-title":"Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.dld.2021.03.035_bib0102","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.cgh.2010.03.029","article-title":"Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites","volume":"8","author":"Montoliu","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0103","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/0886022X.2010.541582","article-title":"Clinical spectrum of renal disorders in patients with cirrhosis of liver","volume":"33","author":"Prakash","year":"2011","journal-title":"Ren Fail"},{"key":"10.1016\/j.dld.2021.03.035_bib0104","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1053\/j.gastro.2013.08.051","article-title":"New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection","volume":"145","author":"Wong","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.03.035_bib0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.14218\/JCTH.2015.00015","article-title":"Acute kidney injury in patients with cirrhosis","volume":"3","author":"Russ","year":"2015","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0106","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/jgh.13002","article-title":"Impact of acute kidney injury on prognosis of patients with liver cirrhosis and ascites: A retrospective cohort study","volume":"30","author":"Bucsics","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0107","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.25735","article-title":"Association of AKI with mortality and complications in hospitalized patients with cirrhosis","volume":"57","author":"Belcher","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0108","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00134-005-2842-7","article-title":"The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis","volume":"31","author":"du Cheyron","year":"2005","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.dld.2021.03.035_bib0109","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/ndt\/gfs067","article-title":"Renal failure in cirrhosis: prerenal azotemia, hepatorenal syndrome and acute tubular necrosis","volume":"27","author":"Schrier","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.dld.2021.03.035_bib0110","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/TP.0000000000002305","article-title":"Acute kidney injury after liver transplantation","volume":"102","author":"Durand","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0111","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/hepr.13224","article-title":"Beyond serum creatinine: which tools to evaluate renal function in cirrhotic patients?","volume":"48","author":"Carrier","year":"2018","journal-title":"Hepatol Res"},{"key":"10.1016\/j.dld.2021.03.035_bib0112","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/cc11188","article-title":"Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"16","author":"Nadim","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.dld.2021.03.035_bib0113","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/lt.20017","article-title":"Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations","volume":"10","author":"Gonwa","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2021.03.035_bib0114","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/nep.13226","article-title":"Biomarkers for acute kidney injury in decompensated cirrhosis: a prospective study","volume":"24","author":"Jaques","year":"2019","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.dld.2021.03.035_bib0115","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/TP.0000000000000552","article-title":"Serum Cystatin C as an indicator of renal function and mortality in liver transplant recipients","volume":"99","author":"Allen","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0116","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/003655102753611753","article-title":"Plasma cystatin C as a marker of renal function in patients with liver cirrhosis","volume":"62","author":"Randers","year":"2002","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.dld.2021.03.035_bib0117","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0016-5085(87)90327-1","article-title":"Effects of renal impairment on liver transplantation","volume":"93","author":"Rimola","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.03.035_bib0118","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.1840060519","article-title":"Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation","volume":"6","author":"Cuervas-Mons","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0119","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00007890-199502150-00010","article-title":"Impact of pretransplant renal function on survival after liver transplantation","volume":"59","author":"Gonwa","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0120","article-title":"Response to Terlipressin and Albumin is associated with improved liver transplant outcomes in patients with hepatorenal syndrome","author":"Piano","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0121","first-page":"538","article-title":"Factors related to renal dysfunction after liver transplantation in patients with normal preoperative function","volume":"53","author":"Koo","year":"2006","journal-title":"Rev Esp Anestesiol Reanim"},{"key":"10.1016\/j.dld.2021.03.035_bib0122","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJM199411243312104","article-title":"Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents","volume":"331","author":"Solomon","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2021.03.035_bib0123","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.25735","article-title":"Association of AKI With Mortality and Complications in Hospitalized Patients With Cirrhosis","volume":"57","author":"Belcher","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0124","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic Kidney Disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2021.03.035_bib0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-018-0009-4","article-title":"Cryoglobulinaemia","volume":"4","author":"Roccatello","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.dld.2021.03.035_bib0126","doi-asserted-by":"crossref","first-page":"364","DOI":"10.5604\/01.3001.0011.7382","article-title":"Association between Hepatitis C Virus and Chronic Kidney Disease: a systematic review and meta-analysis","volume":"17","author":"Fabrizi","year":"2018","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0127","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.ajkd.2010.09.023","article-title":"HCV infection and the incidence of CKD","volume":"57","author":"Butt","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.dld.2021.03.035_bib0128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0129","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.dld.2021.03.035_bib0130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/liv.13992","article-title":"Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease","volume":"39","author":"Paik","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0131","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.metabol.2017.11.003","article-title":"Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis","volume":"79","author":"Mantovani","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.dld.2021.03.035_bib0132","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122082","article-title":"Pathophysiology of Non Alcoholic Fatty Liver Disease","volume":"17","author":"Petta","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dld.2021.03.035_bib0133","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5604\/16652681.1226813","article-title":"Association between hepatitis B virus and chronic kidney disease: a systematic review and meta-analysis","volume":"16","author":"Fabrizi","year":"2017","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0134","doi-asserted-by":"crossref","first-page":"e14262","DOI":"10.1097\/MD.0000000000014262","article-title":"Association between hepatitis B virus infection and chronic kidney disease: a cross-sectional study from 3 million population aged 20 to 49 years in rural China","volume":"98","author":"Du","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.dld.2021.03.035_bib0135","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/joim.12964","article-title":"Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study","volume":"286","author":"Park","year":"2019","journal-title":"J Intern Med"},{"key":"10.1016\/j.dld.2021.03.035_bib0136","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/liv.14125","article-title":"Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: a secondary analysis","volume":"39","author":"Wilechansky","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0137","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2014.05.019","article-title":"CKD and nonalcoholic fatty liver disease","volume":"64","author":"Targher","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.dld.2021.03.035_bib0138","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.aohep.2019.07.013","article-title":"Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?","volume":"19","author":"Kiapidou","year":"2020","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0139","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrneph.2017.16","article-title":"Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease","volume":"13","author":"Targher","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0140","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/TP.0000000000000945","article-title":"Nonalcoholic Steatohepatitis is the most rapidly growing indication for simultaneous liver kidney transplantation in the United States","volume":"100","author":"Singal","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0141","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.4852","article-title":"Comparison of the complexity of patients seen by different medical subspecialists in a universal health care system","volume":"1","author":"Tonelli","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.dld.2021.03.035_bib0142","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/advances\/nmz028","article-title":"Gastrointestinal microbiota in patients with chronic kidney disease: a systematic review","volume":"10","author":"Chung","year":"2019","journal-title":"Adv Nutr"},{"key":"10.1016\/j.dld.2021.03.035_bib0143","first-page":"10","article-title":"Role of Uremic Toxins for kidney, cardiovascular, and bone dysfunction","author":"Fujii","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.dld.2021.03.035_bib0144","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000479252","article-title":"Middle-Molecule uremic toxins and outcomes in chronic kidney disease","volume":"191","author":"Massy","year":"2017","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.jrn.2014.10.009","article-title":"Cardiorenal syndrome: role of protein-bound uremic toxins","volume":"25","author":"Lekawanvijit","year":"2015","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.dld.2021.03.035_bib0146","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/sdi.12757","article-title":"The epidemiology of HCV infection in patients with advanced CKD\/ESRD: A global perspective","volume":"32","author":"Fabrizi","year":"2019","journal-title":"Semin Dial"},{"key":"10.1016\/j.dld.2021.03.035_bib0147","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4254\/wjh.v11.i1.109","article-title":"High prevalence of occult hepatitis C infection in predialysis patients","volume":"11","author":"Sette","year":"2019","journal-title":"World J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0148","doi-asserted-by":"crossref","first-page":"e514","DOI":"10.1016\/j.ijid.2011.04.001","article-title":"Incidence of hepatitis C virus infection in patients with chronic kidney disease on conservative therapy","volume":"15","author":"Li Cavoli","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.dld.2021.03.035_bib0149","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/ndt\/gfx381","article-title":"Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease","volume":"34","author":"Chinnadurai","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.dld.2021.03.035_bib0150","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1038\/s41598-018-23014-0","article-title":"Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study","volume":"8","author":"Jang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2021.03.035_bib0151","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.molmed.2015.08.005","article-title":"Emerging Liver-Kidney Interactions in Nonalcoholic Fatty Liver Disease","volume":"21","author":"Musso","year":"2015","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.dld.2021.03.035_bib0152","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2337\/dc13-2704","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes","volume":"37","author":"Targher","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2021.03.035_bib0153","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/lt.21877","article-title":"Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation","volume":"15","author":"Charlton","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2021.03.035_bib0154","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jhep.2014.03.034","article-title":"Chronic kidney disease and associated mortality after liver transplantation\u2013a time-dependent analysis using measured glomerular filtration rate","volume":"61","author":"Allen","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0155","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/08860220600683607","article-title":"Predictive factors for chronic renal failure one year after orthotopic liver transplantation","volume":"28","author":"Guitard","year":"2006","journal-title":"Ren Fail"},{"key":"10.1016\/j.dld.2021.03.035_bib0156","first-page":"343","article-title":"Liver transplantation in Italy: preliminary 10-year report. The Monotematica Aisf-Olt Study Group","volume":"28","author":"Fagiuoli","year":"1996","journal-title":"Ital J Gastroenterol"},{"key":"10.1016\/j.dld.2021.03.035_bib0157","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/jhep.2002.33160","article-title":"Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation","volume":"35","author":"Nair","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0158","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jhep.2018.02.004","article-title":"Recipient characteristics and morbidity and mortality after liver transplantation","volume":"69","author":"Asrani","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0159","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/clpt.2011.117","article-title":"Chronic calcineurin inhibitor use is nephrotoxic","volume":"90","author":"Chapman","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dld.2021.03.035_bib0160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5500\/wjt.v5.i1.26","article-title":"Underestimation of chronic renal dysfunction after liver transplantation: ICEBERG study","volume":"5","author":"Varo","year":"2015","journal-title":"World J Transplant"},{"key":"10.1016\/j.dld.2021.03.035_bib0161","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/TP.0b013e3181fa94b9","article-title":"Long-term renal function in children after liver transplantation","volume":"91","author":"Kivel\u00e4","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0162","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/tri.12138","article-title":"Risk factors for acute renal injury in living donor liver transplantation: evaluation of the RIFLE criteria","volume":"26","author":"Utsumi","year":"2013","journal-title":"Transpl Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0163","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/ajt.12280","article-title":"Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study","volume":"13","author":"Saliba","year":"2013","journal-title":"Am J Transpl"},{"key":"10.1016\/j.dld.2021.03.035_bib0164","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/TP.0000000000001438","article-title":"Use of Everolimus in Liver Transplantation: Recommendations From a Working Group","volume":"101","author":"De Simone","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0165","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/lt.25400","article-title":"Very Early Introduction of Everolimus in De Novo Liver Transplantation: Results of a Multicenter, Prospective, Randomized Trial","volume":"25","author":"Cillo","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2021.03.035_bib0166","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/TP.0b013e318186b8a3","article-title":"Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial","volume":"86","author":"Lupo","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0167","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/apt.14521","article-title":"Systematic review with meta-analysis: de novo non-alcoholic fatty liver disease in liver-transplanted patients","volume":"47","author":"Losurdo","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2021.03.035_bib0168","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/TP.0000000000002484","article-title":"Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation","volume":"103","author":"Younossi","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0169","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.13751","article-title":"Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries","volume":"38","author":"Holmer","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0170","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.metabol.2016.11.003","article-title":"An association of metabolic syndrome and chronic kidney disease from a 10-year prospective cohort study","volume":"67","author":"Huh","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.dld.2021.03.035_bib0171","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1681\/ASN.2015050542","article-title":"CKD Prevalence Varies across the European General Population","volume":"27","author":"Br\u00fcck","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0172","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis","volume":"11","author":"Musso","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.dld.2021.03.035_bib0173","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jhep.2015.02.045","article-title":"Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study","volume":"63","author":"Mellinger","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0174","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000368915","article-title":"Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study","volume":"40","author":"Rahman","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0175","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/liv.14092","article-title":"The relationship between coronary artery disease and cardiovascular events early after liver transplantation","volume":"39","author":"Patel","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0176","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/liv.14185","article-title":"Cardiovascular morbidity and mortality is increased post-liver transplantation even in recipients with no pre-existing risk factors","volume":"39","author":"De Luca","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0177","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0000000000002507","article-title":"The ILTS Consensus Conference on NAFLD\/NASH and Liver Transplantation: Setting the Stage","volume":"103","author":"Burra","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0178","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jhep.2014.11.044","article-title":"Chronic kidney disease (CKD) and NAFLD: time for awareness and screening","volume":"62","author":"Musso","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0179","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/TP.0000000000002485","article-title":"Management of Recurrent and De Novo NAFLD\/NASH After Liver Transplantation","volume":"103","author":"Germani","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0180","article-title":"KDIGO clinical practice guideline for management of blood pressure in CKD","author":"Becker","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0181","unstructured":"https:\/\/kdigo.org\/wp-content\/uploads\/2018\/03\/KDIGO-DM-GL-SoW-Public-Review-FINAL.pdf."},{"key":"10.1016\/j.dld.2021.03.035_bib0182","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.03.035_bib0183","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ahj.2010.08.012","article-title":"Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease","volume":"160","author":"Sharp Collaborative","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.dld.2021.03.035_bib0184","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11901-010-0042-6","article-title":"Hepatitis B and Renal Disease","volume":"9","author":"Chan","year":"2010","journal-title":"Curr Hepat Rep"},{"key":"10.1016\/j.dld.2021.03.035_bib0185","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2215\/CJN.09180816","article-title":"Viral-Associated GN: Hepatitis B and Other Viral Infections","volume":"12","author":"Kupin","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0186","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/596829","article-title":"Hepatitis B Virus Infection and the Kidney: Renal Abnormalities in HBV Patients, Antiviral Drugs Handling, and Specific Follow-Up","volume":"2015","author":"Deray","year":"2015","journal-title":"Adv Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0187","doi-asserted-by":"crossref","DOI":"10.3390\/diseases6020052","article-title":"Renal Impairment in Chronic Hepatitis B: A Review","volume":"6","author":"Kamimura","year":"2018","journal-title":"Diseases"},{"key":"10.1016\/j.dld.2021.03.035_bib0188","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1525-139X.2005.18108.x","article-title":"National surveillance of dialysis-associated diseases in the United States, 2002","volume":"18","author":"Finelli","year":"2005","journal-title":"Semin Dial"},{"key":"10.1016\/j.dld.2021.03.035_bib0189","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJM200205303462202","article-title":"Chronic hepatitis B","volume":"346","author":"Lok","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2021.03.035_bib0190","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/039139880202500203","article-title":"Serological and molecular testing in hepatitis B and the dialysis patient","volume":"25","author":"Fabrizi","year":"2002","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.dld.2021.03.035_bib0191","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/infdis\/135.4.687","article-title":"Hemodialysis-Associated Hepatitis in the United States, 1974","volume":"135","author":"Snydman","year":"1977","journal-title":"J Infect Dis"},{"key":"10.1016\/j.dld.2021.03.035_bib0192","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1159\/000187413","article-title":"Prevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among dialysis patients. The Italian Multicentric Study on Nosocomial and Occupational Risk of Blood-Borne Infections in Dialysis","volume":"64","author":"Petrosillo","year":"1993","journal-title":"Nephron"},{"key":"10.1016\/j.dld.2021.03.035_bib0193","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1046\/j.1523-1755.2003.00017.x","article-title":"Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS","volume":"63","author":"Burdick","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0194","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ki.1996.403","article-title":"ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States","volume":"50","author":"Marcelli","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0195","first-page":"34","article-title":"The impact of oral antiviral therapy on long-term survival of hepatitis B surface antigen-positive patients on haemodialysis","volume":"127","author":"Ow","year":"2014","journal-title":"N Z Med J"},{"key":"10.1016\/j.dld.2021.03.035_bib0196","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","article-title":"PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy","volume":"64","author":"Papatheodoridis","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0197","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/liv.13142","article-title":"Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis","volume":"36","author":"Raffetti","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0198","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/TP.0000000000000234","article-title":"Kidney transplantation alone in end-stage renal disease patients with hepatitis B liver cirrhosis: a single-center experience","volume":"99","author":"Nho","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0199","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00007890-199607270-00025","article-title":"The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection","volume":"62","author":"Fornairon","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0200","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"issue":"2011","key":"10.1016\/j.dld.2021.03.035_bib0201","first-page":"91","article-title":"Clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of Hepatitis C in chronic Kidney Disease","volume":"8","year":"2018","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.dld.2021.03.035_bib0202","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5301\/ijao.5000437","article-title":"Transmission of hepatitis C virus in dialysis units: a systematic review of reports on outbreaks","volume":"38","author":"Fabrizi","year":"2015","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.dld.2021.03.035_bib0203","first-page":"151","article-title":"High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied","volume":"54","author":"Espinosa","year":"2000","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0204","first-page":"15","article-title":"Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA","volume":"68","author":"Barrera","year":"1995","journal-title":"Vox Sang"},{"key":"10.1016\/j.dld.2021.03.035_bib0205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2893.2001.00280.x","article-title":"Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature","volume":"8","author":"Colin","year":"2001","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.dld.2021.03.035_bib0206","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.4254\/wjh.v7.i10.1377","article-title":"Hepatitis C virus: Virology, diagnosis and treatment","volume":"7","author":"Li","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0207","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41581-018-0081-8","article-title":"Hepatitis C virus and the kidney","volume":"15","author":"Pol","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0208","unstructured":"https:\/\/www.webaisf.org\/wp-content\/uploads\/2019\/01\/documento_hcv_200618.pdf."},{"key":"10.1016\/j.dld.2021.03.035_bib0209","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: Final update of the series(\u2606)","volume":"73","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0210","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1542-4758.2011.00662.x","article-title":"High false-negative rate of anti-HCV among Egyptian patients on regular hemodialysis","volume":"16","author":"El-Sherif","year":"2012","journal-title":"Hemodial Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0211","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jhep.2019.05.028","article-title":"Sofosbuvir\/velpatasvir for 12\u202fweeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis","volume":"71","author":"Borgia","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0212","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2893.2012.01633.x","article-title":"Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?","volume":"19","author":"Fabrizi","year":"2012","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.dld.2021.03.035_bib0213","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1111\/ajt.15582","article-title":"Lessons from the real world: HCV-infected donor kidney transplantation as standard practice","volume":"19","author":"Durand","year":"2019","journal-title":"Am J Transpl"},{"key":"10.1016\/j.dld.2021.03.035_bib0214","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000355615","article-title":"Hepatitis C infection is very rarely treated among hemodialysis patients","volume":"38","author":"Goodkin","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2015.05.020","article-title":"Myeloperoxidase formation of PAF receptor ligands induces PAF receptor-dependent kidney injury during ethanol consumption","volume":"86","author":"Latchoumycandane","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.dld.2021.03.035_bib0216","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.dld.2021.03.035_bib0217","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.semnephrol.2007.10.004","article-title":"Secondary IgA nephropathy","volume":"28","author":"Pouria","year":"2008","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0218","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/ajcp\/89.6.769","article-title":"IgA nephropathy and alcoholic liver cirrhosis. A prospective necropsy study","volume":"89","author":"Bene","year":"1988","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.dld.2021.03.035_bib0219","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0272-6386(87)80053-7","article-title":"Cirrhotic glomerulonephritis: incidence, morphology, clinical features, and pathogenesis","volume":"9","author":"Newell","year":"1987","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.dld.2021.03.035_bib0220","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/ki.2011.276","article-title":"Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases","volume":"80","author":"Tissandi\u00e9","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0221","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.3748\/wjg.v13.i43.5783","article-title":"Association of liver cirrhosis related IgA nephropathy with portal hypertension","volume":"13","author":"Kalambokis","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2021.03.035_bib0222","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/gut.32.2.225","article-title":"IgA nephropathy in non-cirrhotic portal hypertension","volume":"32","author":"Babbs","year":"1991","journal-title":"Gut"},{"key":"10.1016\/j.dld.2021.03.035_bib0223","doi-asserted-by":"crossref","first-page":"895","DOI":"10.5604\/16652681.1171779","article-title":"Contrast-induced acute kidney injury in cirrhotic patients. A retrospective analysis","volume":"14","author":"Safi","year":"2015","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0224","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/lt.25328","article-title":"A validated score predicts Acute Kidney Injury and survival in patients with alcoholic hepatitis","volume":"24","author":"Sujan","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2021.03.035_bib0225","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cgh.2011.09.011","article-title":"Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis","volume":"10","author":"Altamirano","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0226","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1111\/liv.12786","article-title":"The use of beta-blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis","volume":"35","author":"Serst\u00e9","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0227","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/j.semvascsurg.2017.04.001","article-title":"Management of renal dysfunction in patients with liver cirrhosis: role of pretransplantation hemodialysis and outcomes after liver transplantation","volume":"29","author":"Thorat","year":"2016","journal-title":"Semin Vasc Surg"},{"key":"10.1016\/j.dld.2021.03.035_bib0228","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/MNH.0000000000000260","article-title":"Simultaneous liver kidney transplantation","volume":"25","author":"Formica","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.dld.2021.03.035_bib0229","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/TP.0b013e3182590d6b","article-title":"Combined liver-kidney transplantation is preferable to liver transplant alone for cirrhotic patients with renal failure","volume":"94","author":"Fong","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0230","doi-asserted-by":"crossref","first-page":"289","DOI":"10.14218\/JCTH.2017.00065","article-title":"Refining the role of simultaneous liver kidney transplantation","volume":"6","author":"Hussain","year":"2018","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0231","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/TP.0b013e318168476d","article-title":"Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts","volume":"85","author":"Locke","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0232","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/TP.0000000000000438","article-title":"Outcomes of liver transplantation alone after listing for simultaneous kidney: comparison to simultaneous liver kidney transplantation","volume":"99","author":"Hmoud","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0233","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/lt.22008","article-title":"Pretransplant predictors of recovery of renal function after liver transplantation","volume":"16","author":"Northup","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2021.03.035_bib0234","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MCG.0000000000000818","article-title":"MELD stratified outcomes among recipients with diabetes or hypertension: simultaneous liver kidney versus liver alone","volume":"52","author":"Singal","year":"2018","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2021.03.035_bib0235","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cgh.2019.05.057","article-title":"Potential Benefits of Switching Liver Transplant Recipients to Tenofovir Alafenamide Prophylaxis","volume":"18","author":"Sripongpun","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0236","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/hep.23478","article-title":"Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis","volume":"51","author":"Garcia-Tsao","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0237","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jhep.2019.07.007","article-title":"The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery","volume":"71","author":"Reverter","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.03.035_bib0238","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/liv.13755","article-title":"Specific issues concerning the management of patients on the waiting list and after liver transplantation","volume":"38","author":"Burra","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0239","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/ndt\/gfw240","article-title":"Prevalence of autosomal dominant polycystic kidney disease in the European Union","volume":"32","author":"Willey","year":"2017","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"10.1016\/j.dld.2021.03.035_bib0240a","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/j.ajkd.2012.08.040","article-title":"Hepatitis C Virus Infection, Mixed Cryoglobulinemia, and Kidney Disease","volume":"61","author":"Fabrizi","year":"2013","journal-title":"American Journal of Kidney Diseases"},{"issue":"7","key":"10.1016\/j.dld.2021.03.035_bib0241a","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/ndt\/gfm205","article-title":"Hepatitis C virus: from entry to renal injury - facts and potentials","volume":"22","author":"Barsoum","year":"2007","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0240","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ajhg.2016.05.004","article-title":"Mutations in GANAB, Encoding the Glucosidase II\u03b1 Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease","volume":"98","author":"Porath","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.dld.2021.03.035_bib0241","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease","volume":"393","author":"Cornec-Le Gall","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2021.03.035_bib0242","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1053\/j.gastro.2006.12.039","article-title":"Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3\u2032,5\u2032-cyclic monophosphate","volume":"132","author":"Masyuk","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.03.035_bib0243","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ng0695-151","article-title":"The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains","volume":"10","author":"Hughes","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.dld.2021.03.035_bib0244","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2017050483","article-title":"Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases","volume":"29","author":"Cornec-Le Gall","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0245","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ndt\/gfv456","article-title":"Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice","volume":"31","author":"Gansevoort","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.dld.2021.03.035_bib0246","series-title":"Position Statement Della Sin Sull'impiego Del Tolvaptan Nei Pazienti Con Rene Policistico Autosomico Dominante","author":"Capasso","year":"2018"},{"key":"10.1016\/j.dld.2021.03.035_bib0247","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0248","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1681\/ASN.2014030297","article-title":"Imaging-based diagnosis of autosomal dominant polycystic kidney disease","volume":"26","author":"Pei","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0249","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","article-title":"Autosomal dominant polycystic kidney disease: the last 3 years","volume":"76","author":"Torres","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0250","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/SLA.0b013e3181fb8dc4","article-title":"Extended liver resection for polycystic liver disease can challenge liver transplantation","volume":"252","author":"Aussilhou","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2021.03.035_bib0251","first-page":"33","article-title":"[ADPKD: predictors of Renal Disease progression]","author":"Scolari","year":"2016","journal-title":"G Ital Nefrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0252","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"26","author":"Irazabal","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0253","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0254","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1681\/ASN.2015010016","article-title":"The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease","volume":"27","author":"Cornec-Le Gall","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0255","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40265-019-1056-1","article-title":"Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease","volume":"79","author":"Blair","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.dld.2021.03.035_bib0256","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2021.03.035_bib0257","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/ndt\/gfx079","article-title":"Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial","volume":"32","author":"Torres","year":"2017","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.dld.2021.03.035_bib0258","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.kint.2017.12.002","article-title":"REPRISE: tolvaptan in advanced polycystic kidney disease","volume":"93","author":"Wyatt","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0259","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1001\/jama.2018.15870","article-title":"Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial","volume":"320","author":"Meijer","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.dld.2021.03.035_bib0260","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0140-6736(13)61407-5","article-title":"Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial","volume":"382","author":"Caroli","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2021.03.035_bib0261","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002777","article-title":"Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial","volume":"16","author":"Perico","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.dld.2021.03.035_bib0262","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1681\/ASN.2009121302","article-title":"Sirolimus therapy to halt the progression of ADPKD","volume":"21","author":"Perico","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0263","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2021.03.035_bib0264","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2021.03.035_bib0265","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1681\/ASN.2009121291","article-title":"Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease","volume":"21","author":"Hogan","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0266","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1053\/j.gastro.2009.07.052","article-title":"Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial","volume":"137","author":"van Keimpema","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.03.035_bib0267","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1478-3231.2010.02247.x","article-title":"Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases","volume":"31","author":"Van Keimpema","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0268","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00000658-199703000-00008","article-title":"Adult polycystic liver disease: is fenestration the most adequate operation for long-term management?","volume":"225","author":"Gigot","year":"1997","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2021.03.035_bib0269","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/SLA.0b013e3181ad83dc","article-title":"Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation","volume":"250","author":"Schnelldorfer","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2021.03.035_bib0270","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/bjs.6738","article-title":"Treatment of polycystic liver disease","volume":"96","author":"van Keimpema","year":"2009","journal-title":"Br J Surg"},{"key":"10.1016\/j.dld.2021.03.035_bib0271","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1386-6346(99)00067-4","article-title":"Alcohol sclerotherapy of hepatic cysts: its effect in relation to ethanol concentration","volume":"17","author":"Okano","year":"2000","journal-title":"Hepatol Res"},{"key":"10.1016\/j.dld.2021.03.035_bib0272","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/hep.28545","article-title":"Development and validation of a disease-specific questionnaire to assess patient-reported symptoms in polycystic liver disease","volume":"64","author":"Neijenhuis","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0273","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1007\/s00330-018-5851-y","article-title":"Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts","volume":"29","author":"Neijenhuis","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.dld.2021.03.035_bib0274","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00261-012-9931-1","article-title":"Treatment of symptomatic polycystic liver disease: transcatheter super-selective hepatic arterial embolization using a mixture of NBCA and iodized oil","volume":"38","author":"Wang","year":"2013","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.dld.2021.03.035_bib0275","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.4103\/0366-6999.211882","article-title":"Transarterial Embolization for Treatment of Symptomatic Polycystic Liver Disease: More than 2-year Follow-up","volume":"130","author":"Zhang","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.dld.2021.03.035_bib0276","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00464-018-6490-8","article-title":"Clinical response after laparoscopic fenestration of symptomatic hepatic cysts: a systematic review and meta-analysis","volume":"33","author":"Bernts","year":"2019","journal-title":"Surg Endosc"},{"key":"10.1016\/j.dld.2021.03.035_bib0277","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.amjsurg.2004.03.011","article-title":"Laparoscopic fenestration for the treatment of patients with severe adult polycystic liver disease","volume":"189","author":"Konstadoulakis","year":"2005","journal-title":"Am J Surg"},{"key":"10.1016\/j.dld.2021.03.035_bib0278","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00000658-199402000-00007","article-title":"Laparoscopic management of symptomatic nonparasitic cysts of the liver. Indications and results","volume":"219","author":"Morino","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2021.03.035_bib0279","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/bjs.1800831211","article-title":"Laparoscopic fenestration in polycystic liver disease","volume":"83","author":"Kabbej","year":"1996","journal-title":"Br J Surg"},{"key":"10.1016\/j.dld.2021.03.035_bib0280","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/gut.2004.046524","article-title":"The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection","volume":"54","author":"Schindl","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.dld.2021.03.035_bib0281","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jviscsurg.2018.07.004","article-title":"Treatment of polycystic liver disease. Update on the management","volume":"155","author":"Aussilhou","year":"2018","journal-title":"J Visc Surg"},{"key":"10.1016\/j.dld.2021.03.035_bib0282","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/hep.24036","article-title":"Medical and surgical treatment options for polycystic liver disease","volume":"52","author":"Drenth","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0283","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamasurg.2014.307","article-title":"Management of symptomatic polycystic liver disease with hepatic resection","volume":"150","author":"Tseng","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/j.dld.2021.03.035_bib0284","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/tri.12217","article-title":"Factors influencing long-term outcome after kidney transplantation","volume":"27","author":"Legendre","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0285","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(94)92026-5","article-title":"Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1","volume":"343","author":"Ravine","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2021.03.035_bib0286","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1432-2277.2011.01237.x","article-title":"Outcomes of renal transplantation in patients with autosomal dominant polycystic kidney disease: a nationwide longitudinal study","volume":"24","author":"Jacquet","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0287","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00007890-199901270-00013","article-title":"Increased incidence of gastrointestinal surgical complications in renal transplant recipients with polycystic kidney disease","volume":"67","author":"Andreoni","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0288","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jcjd.2016.03.001","article-title":"The risk for new-onset diabetes mellitus after kidney transplantation in patients with autosomal dominant polycystic kidney disease: a systematic review and meta-analysis","volume":"40","author":"Cheungpasitporn","year":"2016","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.dld.2021.03.035_bib0289","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2215\/CJN.01870309","article-title":"Cyst infections in patients with autosomal dominant polycystic kidney disease","volume":"4","author":"Sall\u00e9e","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0290","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cmi.2015.09.024","article-title":"Diagnostic performance of [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography in cyst infection in patients with autosomal dominant polycystic kidney disease","volume":"22","author":"Bobot","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.dld.2021.03.035_bib0291","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1016\/j.transproceed.2019.08.010","article-title":"Native Nephrectomy in Patients With Autosomal Dominant Polycystic Kidney Disease Evaluated for Kidney Transplantation","volume":"51","author":"Anselmo","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.dld.2021.03.035_bib0292","series-title":"Clinical practise guideline on the evaluation and management of candidates for kidney transplantation","year":"2018"},{"key":"10.1016\/j.dld.2021.03.035_bib0293","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/01.ASN.0000118527.74850.66","article-title":"Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease with initially negative studies: a prospective ten-year follow-up","volume":"15","author":"Schrier","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0294","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1212\/WNL.0000000000004597","article-title":"Polycystic kidney disease among 4,436 intracranial aneurysm patients from a defined population","volume":"89","author":"Nurmonen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.dld.2021.03.035_bib0295","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00415-003-0997-0","article-title":"Characteristics of intracranial aneurysms and subarachnoid haemorrhage in patients with polycystic kidney disease","volume":"250","author":"Gieteling","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.dld.2021.03.035_bib0296","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s40620-016-0349-7","article-title":"ADPKD: clinical issues before and after renal transplantation","volume":"29","author":"Messa","year":"2016","journal-title":"J Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0297","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/TP.0b013e31820f0877","article-title":"Incidence and risk factors of glucose metabolism disorders in kidney transplant recipients: role of systematic screening by oral glucose tolerance test","volume":"91","author":"Caillard","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0298","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/TP.0b013e318191e729","article-title":"DNA testing for live kidney donors at risk for autosomal dominant polycystic kidney disease","volume":"87","author":"Huang","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0299","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/hpb.12330","article-title":"Clinical classification of Caroli's disease: an analysis of 30 patients","volume":"17","author":"Wang","year":"2015","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.dld.2021.03.035_bib0300","first-page":"175","article-title":"Evaluation of long-term results of Caroli's disease: 21 years' observation of a family with autosomal \"dominant\" inheritance, and review of the literature","volume":"42","author":"Tsuchida","year":"1995","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.dld.2021.03.035_bib0301","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/lt.20719","article-title":"Caroli's disease and orthotopic liver transplantation","volume":"12","author":"Habib","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2021.03.035_bib0302","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1432-2277.2006.00292.x","article-title":"The place of liver transplantation in Caroli's disease and syndrome","volume":"19","author":"De Kerckhove","year":"2006","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.dld.2021.03.035_bib0303a","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/lt.21366","article-title":"Caroli's disease and outcomes after liver transplantation","volume":"14","author":"Millwala","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2021.03.035_bib0303","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","article-title":"Polycystic kidney disease","volume":"60","author":"Harris","year":"2009","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.dld.2021.03.035_bib0304","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/ndt\/gfr588","article-title":"Kidney and liver transplantation in patients with autosomal recessive polycystic kidney disease: a multicentric study","volume":"27","author":"Chapal","year":"2012","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.dld.2021.03.035_bib0305","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.1038\/s41598-019-43488-w","article-title":"Clinical courses and complications of young adults with Autosomal Recessive Polycystic Kidney Disease (ARPKD)","volume":"9","author":"Burgmaier","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2021.03.035_bib0306","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2036.2011.04783.x","article-title":"Systematic review: the pathophysiology and management of polycystic liver disease","volume":"34","author":"Temmerman","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2021.03.035_bib0307","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/j.ackd.2009.12.005","article-title":"Isolated polycystic liver disease","volume":"17","author":"Qian","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.dld.2021.03.035_bib0308","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-2007-1007313","article-title":"Combined cystic disease of the liver and kidney","volume":"14","author":"D'Agata","year":"1994","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2021.03.035_bib0309","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000479436","article-title":"The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney Disease","volume":"46","author":"D'Agnolo","year":"2017","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.dld.2021.03.035_bib0310","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/liv.12726","article-title":"Effect of lanreotide on polycystic liver and kidneys in autosomal dominant polycystic kidney disease: an observational trial","volume":"35","author":"Gevers","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0311","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.1840400404","article-title":"Polycystic disease of the liver","volume":"40","author":"Everson","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0312","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/lt.20780","article-title":"Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation","volume":"12","author":"Kirchner","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2021.03.035_bib0313","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1002\/lt.20974","article-title":"Model for end-stage liver disease (MELD) exception for polycystic liver disease","volume":"12","author":"Arrazola","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2021.03.035_bib0314","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/liv.13041","article-title":"Combined liver-kidney transplantation for polycystic liver and kidney disease: analysis from the United Network for Organ Sharing dataset","volume":"36","author":"Coquillard","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0315","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/01.tp.0000231712.75645.7a","article-title":"Liver and kidney transplantation for polycystic liver and kidney-renal function and outcome","volume":"82","author":"Ueno","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0316","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1600-6143.2007.01856.x","article-title":"Simultaneous liver-kidney transplantation: evaluation to decision making","author":"Davis","year":"2007","journal-title":"Am J Transpl. United States"},{"key":"10.1016\/j.dld.2021.03.035_bib0317","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/SLA.0000000000001801","article-title":"Avoiding Futility in Simultaneous Liver-kidney Transplantation: Analysis of 331 Consecutive Patients Listed for Dual Organ Replacement","volume":"265","author":"Lunsford","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2021.03.035_bib0318","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/tri.13537","article-title":"Delayed kidney transplantation in combined liver-kidney transplantation for polycystic liver and kidney disease","volume":"32","author":"Lauterio","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0319","first-page":"88","article-title":"Combined liver-kidney transplantation: analysis of patients with preformed lymphocytotoxic antibodies","volume":"20","author":"Fung","year":"1988","journal-title":"Transpl Proc"},{"key":"10.1016\/j.dld.2021.03.035_bib0320","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/292840a0","article-title":"Reversal of transplantation immunity by liver grafting","volume":"292","author":"Kamada","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.dld.2021.03.035_bib0321","first-page":"331","article-title":"Evidence that the liver does not always protect the kidney from hyperacute rejection in combined liver-kidney transplantation across a positive lymphocyte crossmatch","volume":"50","author":"Eid","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0322","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1432-2277.2008.00775.x","article-title":"Humoral and cellular rejection after combined liver-kidney transplantation in low immunologic risk recipients","volume":"22","author":"Hadaya","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.dld.2021.03.035_bib0323","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/00007890-199605150-00021","article-title":"The liver neither protects the kidney from rejection nor improves kidney graft survival after combined liver and kidney transplantation from the same donor","volume":"61","author":"Katznelson","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0324","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1097\/TP.0b013e3182184181","article-title":"Combined liver-kidney transplants: allosensitization and recipient outcomes","volume":"91","author":"Askar","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0325","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/hep.510280218","article-title":"Liver transplantation for adult polycystic liver disease","volume":"28","author":"Swenson","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.03.035_bib0326","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00007890-199808270-00019","article-title":"Liver and kidney transplantation for polycystic disease","volume":"66","author":"Jeyarajah","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2021.03.035_bib0327","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1016\/S0041-1345(97)00696-9","article-title":"Liver transplantation in patients with polycystic liver disease","volume":"29","author":"Lang","year":"1997","journal-title":"Transpl Proc"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821001523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821001523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:16:03Z","timestamp":1761624963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865821001523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":330,"alternative-id":["S1590865821001523"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2021.03.035","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Position paper on liver and kidney diseases from the Italian Association for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN)","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2021.03.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}